title: [Use of bepridil in patients with angina pectoris].
abstract: The efficacy of the calcium antagonist bepridil given in a dose of 200-400 mg/day was evaluated in 22 patients with Functional Classes II-III stable angina pectoris. In addition to clinical assessments, repeated bicycle ergometric exercise tests were performed in the patients. The agent was found to be highly potent, well tolerated, and to cause no grave adverse effects.
authors.forename: E A
authors.initials: EA
authors.lastname: Nekrutman
authors.forename: V P
authors.initials: VP
authors.lastname: Lupanov
authors.forename: A A
authors.initials: AA
authors.lastname: Liakishev
authors.forename: Ia A
authors.initials: IaA
authors.lastname: Podinovskaia
mesh_terms: D000328:Adult; D000787:Angina Pectoris / Q000188:drug therapy* / Q000209:etiology; D015764:Bepridil / Q000627:therapeutic use*; D015444:Exercise; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D015764:Bepridil
vernacular_title: Primenenie bepridila u bol'nykh so stenokardieĭ.